IVACC.ST

Intervacc AB (publ) [IVACC.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

IVACC.ST Stock Summary

Top 10 Correlated ETFs

IVACC.ST

Top 10 Correlated Stocks

IVACC.ST

In the News

IVACC.ST Financial details

Company Rating
-
Market Cap
309.76M
Income
-102.85M
Revenue
8.02M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
23 May 2024
P/E
-4.52
Forward P/E
-
PEG
-1.25
P/S
49.08
P/B
1.86
P/C
-
P/FCF
-8.86
Quick Ratio
5.47
Current Ratio
6.4
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.51
EPS next Y
-
EPS next Q
-
EPS this Y
52.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
22.21%
Revenue last 5Y
-7.97%
Revenue Q/Q
-46.23%
EPS Q/Q
-58.73%
-
-
-
-
SMA20
-5.88%
SMA50
4.35%
SMA100
-55.35%
Inst Own
-
Inst Trans
-
ROA
-38%
ROE
-41%
ROC
-0.37%
Gross Margin
-157%
Oper. Margin
-936%
Profit Margin
-1032%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.2-10.46
52W High
-89.7%
52W Low
-65.67%
RSI
60.5
Rel Volume
2.12
Avg Volume
228.21K
Volume
483.88K
Perf Week
11.96%
Perf Month
7.85%
Perf Quarter
-58.3%
Perf Half Y
-57.44%
-
-
-
-
Beta
0.668
-
-
Volatility
0.04%, 0.05%
Prev Close
0.98%
Price
1.03
Change
5.32%

Something similar

Top by Market Cap
VFINX
FXAIX
AMZ.DE
MSF.DE
BRH.DE
Top Correlated ETFs
2B70.DE
SPYH.DE
2B78.DE
DRDR.L
ETLI.DE
Top Correlated Stocks
ILU.DE
0JD3.L
1952.HK
HTJ.F
ML.PA
Similar Market Cap
ICDSLTD.NS
MBTN.SW
XST.TO
HEXI.ST
PINT.L

Company Profile

Healthcare Biotechnology
  • Volume Average 228.21K
  • Market Capitalization 309.76M
  • Employee 15
  • CEO Mr. Jonas Sohlman
  • Headquarters Hägersten,SE
  • IPO Date 2017-04-07
  • Website https://www.intervacc.se

Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company devlops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles. The company also markets and sells veterinary medicines; and provides diagnostic services in veterinary bacteriology for veterinary clinics and stud farms. In addition, it is developing vaccines against streptococcus suis and staphylococcus aureus-infections. It serves customers in Nordic countries and the Baltic states. The company is based in Hägersten, Sweden.